
1. expert rev vaccines. 2017 jul;16(7):1-13. doi: 10.1080/14760584.2017.1333426.
epub 2017 may 30.

the use transgenic parasites malaria vaccine research.

othman as(1)(2), marin-mogollon c(1), salman am(3), franke-fayard bm(1), janse
cj(1), khan sm(1).

author information: 
(1)a leiden malaria research group, parasitology , leiden university medical
center (lumc) , leiden , netherlands.
(2)b faculty health sciences , universiti sultan zainal abidin , terengganu , 
malaysia.
(3)c jenner institute , university oxford , oxford , uk.

introduction: transgenic malaria parasites expressing foreign genes, example 
fluorescent luminescent proteins, used extensively interrogate
parasite biology host-parasite interactions associated malaria
pathology. increasingly transgenic parasites also exploited advance
malaria vaccine development. areas covered: review transgenic malaria
parasites used, vitro vivo, determine protective efficacy of
different antigens vaccination strategies determine immunological
correlates protection. describe chimeric rodent parasites expressing p.
falciparum p. vivax antigens used directly evaluate rank
order human malaria vaccines advancement clinical testing. in
addition, describe transgenic human rodent parasites used to
develop evaluate live (genetically) attenuated vaccines. expert commentary:
transgenic rodent human malaria parasites used identify
vaccine candidate antigens evaluate sub-unit whole organism
vaccines advanced clinical testing. transgenic parasites
combined vivo pre-clinical testing models (e.g. mice) used to
evaluate vaccine safety, potency durability protection well to
uncover critical protective immune responses refine vaccination
strategies.

doi: 10.1080/14760584.2017.1333426 
pmid: 28525963  [indexed medline]

